85-1773-21　Erlotinib Hydrochloride, Free Base, EGFR Inhibitor (CP-358774, OSI-774, Ro 50-8231) 1g　CAS No:183321-74-6　E3452-75B

特徴

• Erlotinib Hydrochloride is an antineoplastic drug. It regulates mechanistic target of rapamycin (mTOR) inhibition, epidermal growth factor receptor down-regulation and epidermal interstitial transformation (EMT) suppression.
• Synonyms:N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride; NSC 718781; CP-358774, OSI-774, Ro 50-8231
• Molecular Formula:C22H23N3O4
• Molecular Weight:393.44
• Purity (HPLC):≥98%
• Appearance:White solid
• Solubility:DMF: 50mg/mlDMF:PBS (pH 7.2) (1:9): 0.1mg/mlDMSO: 25mg/mlEthanol: 0.25mg/ml
• Storage and Stability:Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：1g
• Grade：Highly Purified
• Molecular Formula：C22H23N3O4
• Molecular Weight Non Ab：393.44
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：183321-74-6

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]